Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
The visa battle giving tech companies a headache.

To be or not to be for H-1Bs

The government shutdown continues into its fifth day. It has repercussions for the tech industry, which we’ll get into below.

But first, we want to talk about the visa battle giving tech companies a headache.

When President Donald Trump announced in September plans to dramatically increase the fees associated with the H-1B visa program, which applies to high-skilled workers, a shot of anxiety coursed through the tech industry.

Subscripion logo

You're seeing a preview of our Premium Policy: Tech coverage. Read the full story by subscribing here.

Tech Policy Tech
Advertisement

Presented by PCMA

Thanks to Big Pharma’s egregious prices, Americans are paying the highest prescription drug prices in the world.

 

Their shell game blaming others is designed to keep Americans stuck with high prices.

 

Tell Big Pharma: Just lower the price.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.
Advertisement

Presented by PCMA

Thanks to Big Pharma’s egregious prices, Americans are paying the highest prescription drug prices in the world.

 

Their shell game blaming others is designed to keep Americans stuck with high prices.

 

Tell Big Pharma: Just lower the price.